(Q35128827)

English

Why Iressa failed: toward novel use of kinase inhibitors (outlook).

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

title

Why Iressa failed: toward novel use of kinase inhibitors (outlook). (English)

1 reference

stated in

Europe PubMed Central

6 August 2017

Zbyszek Darzynkiewicz

object named as

Zbigniew Darzynkiewicz

series ordinal

2

0 references

Mikhail Blagosklonny

series ordinal

1

object named as

Mikhail V Blagosklonny

1 reference

stated in

Europe PubMed Central

6 August 2017

1 March 2003

1 reference

stated in

Europe PubMed Central

6 August 2017

Cancer Biology and Therapy

1 reference

stated in

Europe PubMed Central

6 August 2017

2

1 reference

stated in

Europe PubMed Central

6 August 2017

2

1 reference

stated in

Europe PubMed Central

6 August 2017

137-140

1 reference

stated in

Europe PubMed Central

PubMed ID

12750551

retrieved

6 August 2017

Identifiers

DOI

10.4161/CBT.2.2.286

1 reference

stated in

Europe PubMed Central

6 August 2017

release_qkiltjbelbgzbbprqbnlaq2d3m

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/qkiltjbelbgzbbprqbnlaq2d3m

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed ID

12750551

1 reference

stated in

Europe PubMed Central

PubMed ID

12750551

retrieved

6 August 2017

(Q35128827)

Why Iressa failed: toward novel use of kinase inhibitors (outlook).

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)